Guangbo Zhang

Guangbo Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in OncoImmunology
Verified
Journal Article
Open access
HLHuimin Lu
Huimin Lu
TSTongguo Shi
Tongguo Shi
MWMingyuan Wang
Mingyuan Wang
XLXiaomi Li
Xiaomi Li
YGYanzheng Gu
Yanzheng Gu
WCWeichang Chen
Weichang Chen
The immunoregulatory protein B7-H3, a member of the B7 family, has been confirmed to be highly expressed in colon cancer. However, the exact influence of B7-H3 on the features and antitumor ability of γδT cells in colon cancer remains unknown. In the present study, we investigated that the proportions of B7-H3+ γδT cells were distinctly increased in the peripheral blood and tumor tissues of colon cancer patients. B7-H3 blockade or knockdown promoted proliferation, inhibited cell apoptosis and induced the expression of activation markers (CD25 and CD69) on Vδ2 T cells. In contrast, treatment with the B7-H3 agonist 4H7 had the opposite effect. Furthermore, B7-H3 suppressed IFN-γ expression by inhibiting T-bet in Vδ2 T cells. Moreover, B7-H3 mediated the inhibition of Vδ2 T cell cytotoxicity via the downregulation of IFN-γ and perforin/granzyme B expression. More importantly, blocking the B7-H3 function significantly enhanced the cytotoxicity of Vδ2 T cells against colon cancer cells in vivo. Therefore, the inhibition or blockade of B7-H3 is a potential immunotherapeutic approach for colon cancer.

20 October 2023 in Oncogene
Verified
Journal Article
Closed access
PDF file
LSLinqing Sun
Linqing Sun
YCYuqi Chen
Yuqi Chen
LXLu Xia
Lu Xia
JWJiayu Wang
Jiayu Wang
JZJinghan Zhu
Jinghan Zhu
WCWeichang Chen
Weichang Chen

3 September 2023 in Cancer Science
Verified
Journal Article
Open access
HJHaiyan Jin
Haiyan Jin
MZMengxin Zhu
Mengxin Zhu
DZDongze Zhang
Dongze Zhang
XLXiaoshan Liu
Xiaoshan Liu
YGYuesheng Guo
Yuesheng Guo
GZGuangbo Zhang
Guangbo Zhang
Ferroptosis, a newly discovered form of regulated cell death, has been reported to be associated with multiple cancers, including colorectal cancer (CRC). However, the underlying molecular mechanism is still unclear. In this study, we identified B7H3 as a potential regulator of ferroptosis resistance in CRC. B7H3 knockdown decreased but B7H3 overexpression increased the ferroptosis resistance of CRC cells, as evidenced by the expression of ferroptosis‐associated genes (PTGS2, FTL, FTH, and GPX4) and the levels of important indicators of ferroptosis (malondialdehyde, iron load). Moreover, B7H3 promoted ferroptosis resistance by regulating sterol regulatory element binding protein 2 (SREBP2)‐mediated cholesterol metabolism. Both exogenous cholesterol supplementation and treatment with the SREBP2 inhibitor betulin reversed the effect of B7H3 on ferroptosis in CRC cells. Furthermore, we verified that B7H3 downregulated SREBP2 expression by activating the AKT pathway. Additionally, multiplex immunohistochemistry was carried out to show the expression of B7H3, prostaglandin‐endoperoxide synthase 2, and SREBP2 in CRC tumor tissues, which was associated with the prognosis of patients with CRC. In summary, our findings reveal a role for B7H3 in regulating ferroptosis by controlling cholesterol metabolism in CRC.

9 October 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
LCLi Chen
Li Chen
JZJuan Zhang
Juan Zhang
WLWenjun Liu
Wenjun Liu
JXJia Xu
Jia Xu
DZDongze Zhang
Dongze Zhang
XHXue Huang
Xue Huang